Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition

CompletedOBSERVATIONAL
Enrollment

231

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

June 17, 2025

Study Completion Date

June 17, 2025

Conditions
MalnutritionDiabetes
Interventions
OTHER

Oral Nutritional Supplement (ONS)

Diabetes specific oral nutritional supplement

Trial Locations (17)

11009

Hospital Uni. Puerta Del Mar, Cadiz

14004

Hospital Reina Sophia, Córdoba

18014

Hospital Virgen De Las Nieves, Granda

21005

Hospital Juhn Romon Jimenez, Huelva

23007

Hospital Universitario Jaen, Jaén

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital La Paz, Madrid

28050

Hospital Clinico San Carlos, Madrid

29010

Hospital Especialidades Virgen De La Victoria, Málaga

Hospital Regional Malaga, Málaga

35016

Complejo Hospitalario Universitario Insular-Materno infantil, Las Palmas de Gran Canaria

41013

Hospital Virgen Del Rocio, Seville

46010

Hospital Clinico Valencia, Valencia

46026

Hospital La Fe, Valencia

48013

Hospital Universitario Basurto, Bilbao

50009

Hospital Miguel Servet, Zaragoza

Unknown

Hospital Ramon y Cajal, Madrid

All Listed Sponsors
lead

Abbott Nutrition

INDUSTRY

NCT05913193 - Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition | Biotech Hunter | Biotech Hunter